2022 Life Sciences Tech Trends Overview
The Lens: Life Sciences Reinvention in Focus
Release Date: 09/12/2022
Accenture’s Anne Marie O’Halloran: Manufacturing at the Speed of Scientific Innovation
The Lens: Life Sciences Reinvention in Focus
The road from therapies to patients continues beyond the lab and the clinic. Anne Marie O’Halloran joins Tom Lehmann to discuss why CMC and manufacturing are critical and what it takes to scale biopharma production using intelligent technologies.
info_outline
Kyle & Brent Pease: The Wheel of Inclusion
The Lens: Life Sciences Reinvention in Focus
Join Tom Lehmann and brothers Kyle and Brent Pease, co-founders of The Kyle Pease Foundation, as they share how 150+ races together sparked a 15-year movement advancing inclusion in sports and employment for people with disabilities.
info_outline
Sanofi’s Digital Leaders: Closing the Patient Care Gap
The Lens: Life Sciences Reinvention in Focus
What happens after a prescription is written? Pius Hornstein and Fabrice Bocquillon join Tom Lehmann to discuss how Sanofi is closing patient care gaps through personalized AI support and a reimagined patient experience.
info_outline
BMS' Matteo di Tommaso: AI-Powered Pharma R&D
The Lens: Life Sciences Reinvention in Focus
Tom Lehmann and Matteo di Tommaso, SVP and Head of Research and Development IT, at Bristol-Myers Squibb, explore approaches to scale AI across drug development, discussing a predict-first mindset to human-led platforms driving real impact on how medicines reach patients.
info_outline
2025 Highlights Powering the Path to 2026
The Lens: Life Sciences Reinvention in Focus
Join Tom Lehmann and Petra Jantzer, Accenture’s Global Life Sciences Lead, as they cover the highlights of 2025 and look forward to 2026. What’s coming next for biopharma? Tune in for the trends and insights that will shape the future.
info_outline
Reinventing Merck's Modern Lab: from pipettes to AI
The Lens: Life Sciences Reinvention in Focus
Join Roy Helmy, Associate VP at Merck, as he explores what it takes to reinvent the lab from the ground up. From AI to end-to-end digital transformation of lab operations, Roy shares actionable insights on overcoming resistance and fostering collaboration, and why learning from failure is key to innovation.
info_outline
Innovation Centers Powering Takeda's Digital Future
The Lens: Life Sciences Reinvention in Focus
In this episode, host Tom Lehmann speaks with Sanjay Patel, Global Head of Innovation Capability Solutions & Services at Takeda, regarding how global collaboration and innovative leadership are reshaping the biotech landscape. Sanjay shares insights into the five-hub network he’s building to strengthen Takeda’s data, AI, and product-engineering capabilities through Innovation Capability Centers (ICCs). He discusses the impact of AI and emerging technologies, including Takeda’s internal GenAI assistant “MyAibou,” and how thoughtfully designed workspaces are helping overcome...
info_outline
Marketing Pharma’s Future with GenAI and Purpose
The Lens: Life Sciences Reinvention in Focus
Discover how digital innovation and Gen AI are reshaping pharma with Anvita Karara. Explore how patient-centricity, personalization, and responsible AI are driving better health outcomes and transforming engagement at scale.
info_outline
Tech Trends 2025: Accelerating Autonomy with the Cognitive Digital Brain
The Lens: Life Sciences Reinvention in Focus
An episode with Tracy Ring, Accenture’s Chief Data Officer and Global Generative AI Lead for Life Sciences explores how advanced AI, cognitive digital brains, and agentic systems are transforming business efficiency, trust, and customer interactions.
info_outline
Tech Trends 2025: A partnership between AI and workforce
The Lens: Life Sciences Reinvention in Focus
A discussion with David Hole, Global Life Sciences T&O lead about how GenAI is transforming the life sciences workforce, emphasizing the need for new skills, ethical considerations, and the balance between democratization and governance.
info_outlineIn this episode Tom Lehmann talks with Shalu Chada, Managing Director and Accenture’s Life Sciences Technology Lead, to discuss the 2022 Life Sciences Technology Vision and how each of the report's four trends ingrained in the metaverse are reshaping biopharma experiences of the future.